API: Australian Pharmaceutical Industries Limited - Summary | Jitta

Australian Pharmaceutical Industries Limited

AUS:API

Notice
Stock data is unavailable or the company’s delisted.
Price
AU$1.53
Loss Chance
46.0%
3.52JITTA SCORE
45.78%Under Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (33)
Recent Business Performance (36)
Financial Strength (62)
Return to Shareholders (26)
Competitive Advantage (27)
Jitta Signs
Dividend PayoutEvery year
Interest Coverage RatioVery Good
Cash Conversion CycleLess than 30 days
Revenue and EarningRevenue decline from 2018-2021
Operating MarginInconsistent
Recent Business PerformanceEarning decline 20.22% in the last quarter (yoy)
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.52
45.78%
2.66
158.51%
COMPANY DESCRIPTION
Australian Pharmaceutical Industries Limited engages in the wholesale distribution and retail of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia, New Zealand, and Asian markets. It offers health and beauty products through a network of Priceline and Priceline Pharmacy franchise stores, company-owned Priceline stores, and Clear Skincare network of clinics. The company also provides non-invasive aesthetic beauty services. Australian Pharmaceutical Industries Limited was incorporated in 1910 and is based in Camberwell, Australia. As of March 31, 2022, Australian Pharmaceutical Industries Limited operates as a subsidiary of WFM Investments Pty Ltd.